Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1421866-48-9
2. Nrx-1074
3. Apimostinel [usan]
4. Ttt1f11fzb
5. Apimostinel (usan)
6. (2r)-1-[(2s)-1-[(2s,3r)-2-amino-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]-n-[(2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl]-2-benzylpyrrolidine-2-carboxamide
7. Threonyl-prolyl-2r-(2-benzyl)-prolyl-threonine Amide
8. L-threoninamide, L-threonyl-l-prolyl-2-(phenylmethyl)-l-prolyl-
9. Unii-ttt1f11fzb
10. Apimostinel [inn]
11. Apimostinel [who-dd]
12. Chembl3989872
13. Schembl14682282
14. Nrx1074
15. Dtxsid101031863
16. Agn-241660
17. Db11784
18. Hy-102053
19. Cs-0022853
20. D11299
21. Q27290341
22. L-threonyl-l-prolyl-2-benzyl-l-prolyl-l-threoninamide N-methyl-d-aspartate
| Molecular Weight | 503.6 g/mol |
|---|---|
| Molecular Formula | C25H37N5O6 |
| XLogP3 | -1 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 9 |
| Exact Mass | 503.27438392 g/mol |
| Monoisotopic Mass | 503.27438392 g/mol |
| Topological Polar Surface Area | 179 Ų |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 834 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Apimostinel manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Apimostinel, including repackagers and relabelers. The FDA regulates Apimostinel manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Apimostinel API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Apimostinel supplier is an individual or a company that provides Apimostinel active pharmaceutical ingredient (API) or Apimostinel finished formulations upon request. The Apimostinel suppliers may include Apimostinel API manufacturers, exporters, distributors and traders.
Apimostinel Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Apimostinel GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Apimostinel GMP manufacturer or Apimostinel GMP API supplier for your needs.
A Apimostinel CoA (Certificate of Analysis) is a formal document that attests to Apimostinel's compliance with Apimostinel specifications and serves as a tool for batch-level quality control.
Apimostinel CoA mostly includes findings from lab analyses of a specific batch. For each Apimostinel CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Apimostinel may be tested according to a variety of international standards, such as European Pharmacopoeia (Apimostinel EP), Apimostinel JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Apimostinel USP).
LOOKING FOR A SUPPLIER?
